Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality
The GLP-1 receptor agonists approved for weight loss include: Zepbound (tirzepatide), Saxenda (liraglutide), and Wegovy (semaglutide)
Below, we discuss the effects that GLP-1 RAs have and how they work for diabetes and weight loss
This psychological lag is normal and gradually resolves as the new body becomes the familiar one
However, if you have food allergies, you should be aware that all our meals are made in a kitchen that also produces meals with wheat, oats, gluten, fish, seafood, dairy, eggs, soy, nuts and seeds